|
RAB33B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.217200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.608900E-04 |
| Normal-vs-Stage2 |
3.946000E-01 |
| Normal-vs-Stage3 |
2.261200E-01 |
| Normal-vs-Stage4 |
9.386200E-01 |
| Stage1-vs-Stage2 |
2.320600E-01 |
| Stage1-vs-Stage3 |
3.382000E-01 |
| Stage1-vs-Stage4 |
2.618800E-01 |
| Stage2-vs-Stage3 |
8.072600E-01 |
| Stage2-vs-Stage4 |
5.756400E-01 |
| Stage3-vs-Stage4 |
4.592200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.806300E-04 |
| Normal-vs-AfricanAmerican |
2.756400E-02 |
| Normal-vs-Asian |
9.178400E-03 |
| Caucasian-vs-AfricanAmerican |
6.335000E-01 |
| Caucasian-vs-Asian |
2.046000E-01 |
| AfricanAmerican-vs-Asian |
1.477770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.797500E-04 |
| Normal-vs-Female |
1.581590E-02 |
| Male-vs-Female |
5.759800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.400300E-03 |
| Normal-vs-Extreme_Weight |
9.768300E-04 |
| Normal-vs-Obese |
1.024400E-01 |
| Normal-vs-Extreme_Obese |
2.588000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.956400E-01 |
| Normal_Weight-vs-Obese |
2.112600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.095200E-01 |
| Extreme_Weight-vs-Obese |
1.440240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.966800E-01 |
| Obese-vs-Extreme_Obese |
7.226400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.793750E-02 |
| Normal-vs-Age(41-60Yrs) |
1.340230E-01 |
| Normal-vs-Age(61-80Yrs) |
5.68679999999322E-05 |
| Normal-vs-Age(81-100Yrs) |
1.841690E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.165800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.373400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.172000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.942500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.522100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.674000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.482000E-03 |
| Normal-VS-Type2 PRCC |
8.22750000000205E-05 |
| Normal-VS-KIRP CIMP |
5.076000E-02 |
| Normal-VS-Unclassified PRCC |
8.245200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.012190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.506000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.908300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.778000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.340300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.029400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.258600E-03 |
| Normal-vs-N1 |
2.773600E-01 |
| Normal-vs-N2 |
4.508100E-02 |
| N0-vs-N1 |
3.422600E-01 |
| N0-vs-N2 |
7.807800E-01 |
| N1-vs-N2 |
5.222800E-01 |
|
|
